Stanford Drug Discovery Symposium runs April 19-20

The annual conference will feature an interdisciplinary cast of researchers, industry leaders and policymakers who will discuss advances in therapeutics, including COVID-19 treatments.

Registration is open for the 2021 Stanford Drug Discovery Symposium, which will take place virtually April 19-20.

The conference, which is free and open to the public, will feature dozens of academic researchers, industry leaders, investors, policymakers and others discussing a broad range of topics related to drug research and development.

Highlights will include a panel discussion on changes in the drug industry brought about by the outbreak of COVID-19 and talks on new manufacturing techniques.

Speakers this year include Stanford’s Brian Kobilka, MD, the Hélène Irwin Fagan Chair in Cardiology and winner of the 2012 Nobel Prize in chemistry; Stanford’s Roger Kornberg, PhD, the Mrs. George A. Winzer Professor in Medicine and winner of the 2006 Nobel Prize in Chemistry; and Janet Woodcock, MD, acting commissioner of the Food and Drug Administration.

Lifetime achievement awards will be presented to Douglas Lowy, MD, principal deputy director of the National Cancer Institute, and John Schiller, PhD, deputy chief of the cellular oncology laboratory at the National Cancer Institute for their work on the human papilloma virus vaccine. 

The Stanford Cardiovascular Insitute is organizing the event. Conference registration is available online



Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at http://mednews.stanford.edu.

COVID-19 Updates

Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.

Leading In Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.